AIGENDRUG Co., Ltd.
AIGENDRUG is an AI-driven drug discovery company that aims to contribute to human health by broadening drug discovery research. Their platform, DrugVLAB™, leverages AI to explore chemical, genetic, and disease spaces, enabling efficient identification of drug candidates, prediction of drug efficacy, ADME, and toxicity, and patient stratification. The company offers standalone tools, pre-built packages, and customized AI services to optimize the drug development process, reduce costs, and minimize risks associated with preclinical and clinical stages. They have a history of securing seed investment, participating in industry events like BIO USA, and collaborating with institutions like Seoul National University.
AIGENDRUG Co., Ltd.
AIGENDRUG is an AI-driven drug discovery company that aims to contribute to human health by broadening drug discovery research. Their platform, DrugVLAB™, leverages AI to explore chemical, genetic, and disease spaces, enabling efficient identification of drug candidates, prediction of drug efficacy, ADME, and toxicity, and patient stratification. The company offers standalone tools, pre-built packages, and customized AI services to optimize the drug development process, reduce costs, and minimize risks associated with preclinical and clinical stages. They have a history of securing seed investment, participating in industry events like BIO USA, and collaborating with institutions like Seoul National University.